Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies

Lasers in Surgery and Medicine

Volumn 18, Issue 1, 1996, Pages 39-45

  Ris, Hans Beat ^a   Altermatt, Hans J ^a   Nachbur, Bernhard ^a   Stewart, Charles M ^b   Wang, Qiang ^c   Lim, Chung K ^c   Bonnett, Raymond ^d   Althaus, Ulrich ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Scotia Pharmaceuticals   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

m tetrahydroxyphenylchlorin; malignant histiocytoma; malignant mesothelioma; photochemotherapy; surgical tumor resection

Indexed keywords

PHOTOSENSITIZING AGENT; TETRAHYDROXYPHENYLCHLORIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; INTRAOPERATIVE PERIOD; INTRAVENOUS DRUG ADMINISTRATION; MALIGNANT FIBROUS HISTIOCYTOMA; MALIGNANT MESOTHELIOMA; PHASE 1 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR NECROSIS;

ANTINEOPLASTIC AGENTS; BRACHIAL PLEXUS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEASIBILITY STUDIES; HUMANS; INFARCTION; INTRAOPERATIVE CARE; MESOPORPHYRINS; MESOTHELIOMA; NECROSIS; NEOPLASM INVASIVENESS; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; SKIN; THORACIC NEOPLASMS; THORACOTOMY; THROMBOSIS;

EID: 0030050239     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9101(1996)18:1<39::AID-LSM5>3.0.CO;2-S     Document Type: Article

References (22)

1. Nambisan RN, Karakousis CP, Holyoke ED, Dougherty TJ. Intraoperative photodynamic therapy for retroperitoneal sarcomas. Cancer 1988; 61:1248-1252.
2. Sindelar WF, DeLaney TF, Tochner Z, Thomas GF, Smith PD, Friauf WS, Gladstein E. Technique of photodynamic therapy for disseminated intraperitoneal malignant neoplasms. Arch Surg 1991; 126:318-324.
3. Pass HI, Tochner Z, DeLaney T, Smith PD, Friauf WS, Glatstein E, Travis W. Intraoperative photodynamic therapy for malignant mesothelioma; Letter to the editor. Ann Thorac Surg 1990; 50:687-688.
4. Lofgren L, Larsson M, Thanning L, Hallgren S. Transthoracic endoscopic photodynamic treatment of malignant mesothelioma. Lancet 1991; 337:359.
5. Ris HB, Altermatt HJ, Inderbitzi R, Hess R, Nachbur B, Stewart JCM, Bonnet R, Berenbaum MC, Althaus U. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: Initial clinical results. Br J Cancer 1991, 64:1116-1120.
6. Berenbaum MC. Comparison of hematoporphyrin derivatives and new photosensitizers. In: Ciba Foundation Symposium 146, "Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use." Chichester: John Wiley & Sons, 1989, pp. 33, 34.
7. Ris HB, Altermatt HJ, Nachbur B, Stewart JCM, Wang Q, Lim CK, Bonnett R, Althaus U. Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma. Int J Cancer 1993; 53:141-146.
8. Ris HB, Altermatt HJ, Stewart JCM, Schaffher T, Wang Q, Lim CK, Bonnett R, Althaus U. Photodynamic therapy with m-tetrahydroxyphenylchlorin in vivo: Optimization of the therapeutic index. Int J Cancer 1993; 55:245-249.
9. Wang Q, Ris HB, Altermatt HJ, Reynolds B, Stewart JCM, Bonnett R, Lim CK. Determination of 5,10,15,20-Tetra(m-hydroxyphenyl)chlorin in human plasma by high performance liquid chromatography. Biomedical Chromatography 1993, 7:45-47.
10. Wang Q, Altermatt HJ, Ris HB, Reynolds B, Stewart JCM, Bonnett R, Lim CK. Determination of 5,10,15,20-Tetra(m-hydroxyphenyl)chlorin in tissue by high performance liquid chromatography. Biomedical Chromatography 1993, 7:155-157.
11. Antmann KH, Li FP, Osteen R. Mesothelioma. Cancer Updates 1989; 3:1-16.
12. Alberts AS, Falkson G, Goedhals L, Vorobiof DA, Van DerMerve CA. Malignant pleural mesothelioma: A disease unaffected by current therapeutic maneuvers. J Clin Oncol 1988; 6:527-534.
13. Brady LW. Mesothelioma - the role for radiation therapy. Semin Oncol 1981; 8:329-334.
14. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: A lung cancer study group trial. J Thorac Cardiovasc Surg 1991; 102:1-9.
15. Faber F. Surgical treatment of asbestos-related disease. Surg Clin N Am 1988; 68:525-543.
16. Feins RH, Hilf R, Ross H, Gibson SL. Photodynamic therapy for human malignant mesothelioma in the nude mouse. J Surg Res 1990; 49:311-314.
17. Shemin RJ. Surgical treatment of pleural mesothelioma. In: Antmann KH, Aisner J, eds. "Asbestos-related Malignancy." Orlando: Grune & Stratton, 1987, pp 323-337.
18. Butchart EG, Surgery of mesothelioma of the pleura. In: Roth JA, Ruckdeschel JC, Weisenburger TH, eds. "Thoracic Oncology." Philadelphia: WB Saunders, 1989, pp 566-583.
19. Bonnett R, Berenbaum MC. Porphyrins as sensitizers. In: Ciba Foundation Symposium 146, "Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use." Chichester: John Wiley & Sons, 1989, pp 40-53.
20. Van Lier JE, Spikes JD. The chemistry, photophysics and photosensitizing properties of phthalocyanines. In: Ciba Foundation Symposium 146, "Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use." Chichester: John Wiley & Sons, 1989, pp 17-26.
21. Pandey RK, Bellnier DA, Smith KM, Dougherty TJ. Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochem Photobiol 1991; 53:65-72.
22. Nauta RJ, Osteen RT, Antmann KH, Koster JK. Clinical staging and the tendency of malignant pleural mesothelioma to remain localized. Ann Thorac Surg 1982; 34:66-70.